ALFA Finder| Revenue growth | 13.6% YoY (FY26 vs FY25) |
|---|---|
| Margins | EBITDA margin improved from 14.53% in FY24 to 17.43% in FY26 |
| Order book | Recent wins: ₹1.25 Cr and ₹2.40 Cr STP projects |
| Demand visibility | Strong; driven by affordable housing and government sanitation projects |
| Management confidence | High; expanding infrastructure and diversifying portfolio |
Growth
Turnover grew 19% over two years, reaching ₹1,363.98 lakh in FY26. PAT increased to ₹145.83 lakh in FY26 from ₹114.97 lakh in FY24.
Outlook
Expanding manufacturing capacity to 2.0 lakh sq. ft. in FY26-27 with 70% utilization target. Focus on recurring O&M revenue.
Risks
Regulatory compliance in fire safety and sanitation; competition in green building materials.
Investor Presentation filed with BSE, BSE: 543595. Summary written with AI assistance from the document.
EP Biocomposites Ltd: key numbers
- Share price
- ₹90.01
- Market cap
- ₹15.14 Cr
- Revenue (annual)
- ₹13.64 Cr
- Net profit (annual)
- ₹1.46 Cr
- P/E (TTM)
- 10.4×Sector 21.7×
- Promoter holding
- 70.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EP Biocomposites Ltd
All →EP Biocomposites Other Announcement
This filing submits the quarterly shareholding pattern for EP Biocomposites Ltd as required under Regulation 31(1)(b) of SEBI LODR Regulations.
EP Biocomposites Partnership
EP Biocomposites signed a strategic collaboration and consultancy agreement with Malligavad Foundation and Anand Malligavad for water conservation projects, with no upfront monetary consideration.
EP Biocomposites Bags ₹0.92 Cr Order from Beleza by the Beach
EP Biocomposites Limited secured a ₹0.92 Crore order from Beleza by the Beach to install a 70 KLD Sewage Treatment Plant by April 2027.
- Value
- ₹0.92 Cr
- From
- Beleza by the Beach
- Execution
- 30.04.2027
- Sewage Treatment Plant
- 70.0 KLD
EP Biocomposites Annual General Meeting
EP Biocomposites has shared the draft Chairman’s speech for its 7th Annual General Meeting on September 28, 2026. It highlights recent financial performance and strategic initiatives.
EP Biocomposites Annual Report
EP Biocomposites Ltd has released its 7th Annual Report for the financial year 2025-26, detailing operational highlights and financial performance snapshots.
EP Biocomposites Annual General Meeting
EP Biocomposites Ltd has issued a notice for its 7th Annual General Meeting, scheduled for September 28, 2026, to discuss financial statements and director appointments.